Loading…
Managed Stablecoins are Securities Act of 2019
Legislative Progress
Introduced
November 20, 2019
Latest Action
November 20, 2019
Primary Sponsor
Sylvia R. GarciaDemocratic(TX)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Managed Stablecoins are Securities Act of 2019 This bill establishes managed stablecoins—a type of digital currency the value of which is linked to another asset or group of assets—as a type of security for regulatory purposes.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2020 · fourth_quarter · Computer Industry
Referred to the House Committee on Financial Services.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; diversity and improving education in science, technology and engineering; protecting children, bullying prevention and online safety; human trafficking relief; data portability and interoperability; data breach; net neutrality and connectivity; platform integrity and cybersecurity; storage and access to electronic communications and encryption; blockchain policy; manipulated media; and opioid policy; Section 230 of the Communications Decency Act; Digital Millennium Copyright Act (DMCA); S. 1084, Deceptive Experiences To Online Users Reduction Act (DETOUR Act); USA Freedom Act reauthorization; H.R. 1485, Computer Science for All Act of 2019; S. 1569, Federal Campaign Cybersecurity Assistance Act of 2019; H.R. 2896, Stopping Harmful Image Exploitation and Limiting Distribution Act of 2019 (SHIELD Act of 2019); S. 2658, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS Act); H.R. 5197, Managed Stablecoins are Securities Act of 2019; S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020 (EARN IT Act of 2020); S. 4051, Lawful Access to Encrypted Data Act; S. 3629, Child Safety Investment Act of 2020; S. 4066, Platform Accountability and Consumer Transparency Act (PACT Act); S. 4626, Setting an American Framework to Ensure Data Access, Transparency, and Accountability Act (SAFE DATA Act); H.R. 8323, Biancas Law; S. 4534, The Online Freedom and Viewpoint Diversity Act; S. 5020, A bill to repeal section 230 of the Communications Act of 1934; H.R. 8517, Protect Speech Act; H.R. 133, Consolidated Appropriations Act, 2021 (including Coronavirus Response and Relief Supplemental Appropriations Act, 2021)
Client expense: $4,690,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Banking
Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Blockchain regulatory policy. H.R. 2144 - Token Taxonomy Act. Implementation of Foreign Investment Risk Review Modernization Act -- new export & investment restrictions. DEAL Act and Registered Investment Advisor rules. Volcker Rule reform. Private Securities Transparency and Reform Act, beneficial ownership reporting legislation. H.R. 5197 - Managed Stablecoins are Securities Act of 2019 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136. CARES Act (Main Street Lending Facility). H.R. 600 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Health, Economic Assistance, Liability Protection and Schools (HEALS) Act Delivering Immediate Relief to America's Families, Schools and Small Business Act (Senate Amendment No. 2652 to the House Amendment S. 178) H.R. 7766, To amend the Internal Revenue Code of 1986 to increase the research tax credit and provide better access to the credit for business startups
Client expense: Not reported · Firm income: $60,000
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
2020 · fourth_quarter · Banking
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144 and FinCEN rule regarding convertible virtual currencies; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 8603; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.
Client expense: $847,156 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
2020 · fourth_quarter · Banking
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins and Securities Act of 2019. H.R. 8373, the Digital Commodity Exchange Act of 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Financial Institutions/Investments/Securities
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins are Securities Act of 2019. H.R. 8373, the Digital Commodity Exchange Act of 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3599, Healthcare Workforce Resilience Act: Foreign physician immigration status H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs S.4349, Dr. Lorna Breen Health Care Provider Protection Act: physician health Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Certified Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators, Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Centre for Clinical and Applied Services Provision Research
2020 · third_quarter · Computer Industry
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; diversity and improving education in science, technology and engineering; protecting children, bullying prevention and online safety; human trafficking relief; data portability and interoperability; data breach; net neutrality and connectivity; platform integrity and cybersecurity; storage and access to electronic communications and encryption; blockchain policy; and manipulated media; Section 230 of the Communications Decency Act; Digital Millennium Copyright Act (DMCA); S. 1084, Deceptive Experiences To Online Users Reduction Act (DETOUR Act); USA Freedom Act reauthorization; H.R. 1485, Computer Science for All Act of 2019; S. 1569, Federal Campaign Cybersecurity Assistance Act of 2019; H.R. 2896, Stopping Harmful Image Exploitation and Limiting Distribution Act of 2019 (SHIELD Act of 2019); S. 2658, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS Act); H.R. 5197, Managed Stablecoins are Securities Act of 2019; S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020 (EARN IT Act of 2020); S. 4051, Lawful Access to Encrypted Data Act; S. 3629, Child Safety Investment Act of 2020; S. 4066, Platform Accountability and Consumer Transparency Act (PACT Act); S. _____, Setting an American Framework to Ensure Data Access, Transparency, and Accountability Act (SAFE DATA Act); H.R. 8323, Biancas Law; S. 4534, The Online Freedom and Viewpoint Diversity Act
Client expense: $4,900,000 · Firm income: Not reported
2020 · third_quarter · Computer Industry
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; diversity and improving education in science, technology and engineering; protecting children, bullying prevention and online safety; human trafficking relief; data portability and interoperability; data breach; net neutrality and connectivity; platform integrity and cybersecurity; storage and access to electronic communications and encryption; blockchain policy; and manipulated media; Section 230 of the Communications Decency Act; Digital Millennium Copyright Act (DMCA); S. 1084, Deceptive Experiences To Online Users Reduction Act (DETOUR Act); USA Freedom Act reauthorization; H.R. 1485, Computer Science for All Act of 2019; S. 1569, Federal Campaign Cybersecurity Assistance Act of 2019; H.R. 2896, Stopping Harmful Image Exploitation and Limiting Distribution Act of 2019 (SHIELD Act of 2019); S. 2658, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS Act); H.R. 5197, Managed Stablecoins are Securities Act of 2019; S. 3398, Eliminating Abusive and Rampant Neglect of Interactive Technologies Act of 2020 (EARN IT Act of 2020); S. 4051, Lawful Access to Encrypted Data Act; S. 3629, Child Safety Investment Act of 2020; S. 4066, Platform Accountability and Consumer Transparency Act (PACT Act); S. _____, Setting an American Framework to Ensure Data Access, Transparency, and Accountability Act (SAFE DATA Act); H.R. 8323, Biancas Law; S. 4534, The Online Freedom and Viewpoint Diversity Act
Client expense: $4,900,000 · Firm income: Not reported
2020 · third_quarter · Banking
Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Blockchain regulatory policy. H.R. 2144 - Token Taxonomy Act. Implementation of Foreign Investment Risk Review Modernization Act -- new export & investment restrictions. DEAL Act and Registered Investment Advisor rules. Volcker Rule reform. Private Securities Transparency and Reform Act, beneficial ownership reporting legislation. H.R. 5197 - Managed Stablecoins are Securities Act of 2019 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136. CARES Act (Main Street Lending Facility). H.R. 600 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Health, Economic Assistance, Liability Protection and Schools (HEALS) Act Delivering Immediate Relief to America's Families, Schools and Small Business Act (Senate Amendment No. 2652 to the House Amendment S. 178) H.R. 7766, To amend the Internal Revenue Code of 1986 to increase the research tax credit and provide better access to the credit for business startups
Client expense: Not reported · Firm income: $60,000
2020 · third_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3599, Healthcare Workforce Resilience Act: Foreign physician immigration status H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act: Surprise Medical Bills H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Certified Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators, Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20
2020 · third_quarter · Financial Institutions/Investments/Securities
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins are Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Banking
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins and Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Banking
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.
Client expense: $588,387 · Firm income: Not reported
2020 · second_quarter · Banking
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis; Main Street Loan Program.
Client expense: $609,952 · Firm income: Not reported
- Issues related to policy formulation for digital asset and blockchain technology - HR 2144 The Token Taxonomy Act - HR 5197 - The Managed Stablecoins and Securities Act
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues related to policy formulation for digital asset and blockchain technology - HR 2144 - The Token Taxonomy Act - HR 5197 - The Managed Stablecoins and Securities Act
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to policy formulation for digital asset and blockchain technology HR 2144 - The Token Taxonomy Act HR 5197 - The Managed Stablecoins are Securities Act
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues related to policy formulation for digital asset and blockchain technology - HR 2144 The Token Taxonomy Act - HR 5197 - The Managed Stablecoins and Securities Act
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
- Issues related to policy formulation for digital asset and blockchain technology - HR 2144 - The Token Taxonomy Act - HR 5197 - The Managed Stablecoins and Securities Act
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Computer Industry
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; H.R. 2592/S. 1356, Honest Ads Act; diversity and improving education in science, technology and engineering; protecting children and online safety; human trafficking relief; Section 230 of the Communications Decency Act; general discussions on data breach; discussions regarding net neutrality and connectivity; issues related to opioid policy; The DETOUR Act (Deceptive Experiences To Online Users Reduction), Childrens Online Privacy Protection Rule, bullying prevention efforts, data portability and interoperability; issues related to platform integrity and cybersecurity, storage and access to electronic communications and encryption; discussions on the reauthorization of expiring provisions of the USA Freedom Act H.R. 1485, Computer Science for All Act of 2019; S. 1569, Federal Campaign Cybersecurity Assistance Act of 2019; issues related to blockchain policy; H.R. 2896, SHIELD Act of 2019; ACCESS ACT; H.R. 5197, Managed Stablecoins are Securities Act of 2019; manipulated media; S. 3398, EARN IT Act of 2020; S. 4051, LAED Act of 2020; S. 3629, Child Safety Investment Act of 2020; Digital Millennium Copyright Act (DMCA) S. 4066, Platform Accountability and Consumer Transparency Act
Client expense: $4,830,000 · Firm income: Not reported
2020 · second_quarter · Banking
Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Blockchain regulatory policy. H.R. 2144 - Token Taxonomy Act. Implementation of Foreign Investment Risk Review Modernization Act -- new export & investment restrictions. DEAL Act and Registered Investment Advisor rules. Volcker Rule reform. Private Securities Transparency and Reform Act, beneficial ownership reporting legislation. H.R. 5197 - Managed Stablecoins are Securities Act of 2019 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136. CARES Act (Main Street Lending Facility).
Client expense: Not reported · Firm income: $60,000
2020 · second_quarter · Banking
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins and Securities Act of 2019. CARES Act implementation.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Financial Institutions/Investments/Securities
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins are Securities Act of 2019. CARES Act implementation.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice H.R. 7059, Coronavirus Provider Protection Act: Liability protection for healthcare providers Public Law No: 116-142, Paycheck Protection Program Flexibility Act of 2020 S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl Surprise Medical Bills S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management COVID-19: Increased supply of PPE and ventilators,Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration), insurance moratorium; COVID Update Memorandum 4/21/20 Immigration: Foreign physician immigration status
2020 · first_quarter · Computer Industry
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; Honest Ads Act (S.1356, H.R. 2592); diversity and improving education in science, technology and engineering; protecting children and online safety; human trafficking relief; Section 230 of the Communications Decency Act; general discussions on data breach; discussions regarding net neutrality and connectivity; issues related to opioid policy; The DETOUR Act (Deceptive Experiences To Online Users Reduction), Childrens Online Privacy Protection Rule, bullying prevention efforts, data portability and interoperability; issues related to platform integrity and cybersecurity, storage and access to electronic communications and encryption; discussions on the reauthorization of expiring provisions of the USA Freedom Act Computer Science for All Act of 2019 (H.R. 1485); Federal Campaign Cybersecurity Assistance Act of 2019; issues related to blockchain policy; SHIELD Act of 2019 (H.R. 2896); ACCESS ACT; Managed Stablecoins are Securities Act of 2019, H.R. 5197; manipulated media; S. 3398, EARN IT Act of 2020
Client expense: $5,260,000 · Firm income: Not reported
Issues related to policy formulation for digital asset and blockchain technology HR 2144 - The Token Taxonomy Act HR 5197 - The Managed Stablecoins are Securities Act
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Banking
Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Blockchain regulatory policy. H.R. 2144 - Token Taxonomy Act. Implementation of Foreign Investment Risk Review Modernization Act -- new export & investment restrictions. DEAL Act and Registered Investment Advisor rules. Volcker Rule reform. Private Securities Transparency and Reform Act, beneficial ownership reporting legislation. H.R. 5197 - Managed Stablecoins are Securities Act of 2019 H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136. CARES Act (Main Street Lending Facility).
Client expense: Not reported · Firm income: $60,000
2020 · first_quarter · Financial Institutions/Investments/Securities
Issues related to acceptance and use of digital assets and blockchain-based technologies; S. 2563, ILLICIT CASH Act; H.R. 6154, Crypto-Currency Act of 2020; H.R. 748, CARES Act; H.R. 5197, Managed Stablecoins are Securities Act of 2019; H.R. 4813, Keep Big Tech Out Of Finance Act
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
2020 · first_quarter · Banking
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins and Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Financial Institutions/Investments/Securities
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins are Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
S.3548, CARES Act: To provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic; Practice Support/Grants to Practice S.3201, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: Letter to Congressional Leadership regarding Fentanyl Surprise Medical Bills S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) FY 2021 LHHS Appropriations: Fiscal Year 2021 Appropriations for Subcommittee on Labor, Health and Human Services Outside Witness Testimony Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management Immigration: Foreign Physician Immigration Status COVID-19: Increased supply of PPE and ventilators,Funding for physician practices impacted by the cancellation of elective surgeries, unique role of anesthesiologists in responding to COVID-19 pandemic, medical liability, Scope of Practice (Waiver of federal supervision requirement under the Emergency Declaration)
2020 · first_quarter · Banking
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis
Client expense: $569,176 · Firm income: Not reported
2019 · fourth_quarter · Computer Industry
Issues and discussions related to technology and the Internet including privacy, security, competition, and research; online advertising, content and platform transparency efforts; Honest Ads Act (S.1356, H.R. 2592); diversity and improving education in science, technology and engineering; protecting children and online safety; human trafficking relief; Section 230 of the Communications Decency Act; general discussions on data breach; discussions regarding net neutrality and connectivity; issues related to opioid policy; The DETOUR Act (Deceptive Experiences To Online Users Reduction), Childrens Online Privacy Protection Rule, bullying prevention efforts, data portability and interoperability; issues related to platform integrity and cybersecurity, storage and access to electronic communications and encryption; discussions on the reauthorization of expiring provisions of the USA Freedom Act Computer Science for All Act of 2019 (H.R. 1485); Federal Campaign Cybersecurity Assistance Act of 2019; issues related to blockchain policy; SHIELD Act of 2019 (H.R. 2896); ACCESS ACT; Managed Stablecoins are Securities Act of 2019, H.R. 5197; manipulated media
Client expense: $4,430,000 · Firm income: Not reported
2019 · fourth_quarter · Banking
Policies to encourage and empower entrepreneurship, including streamlined regulations at the SEC. Capital markets reforms to encourage more U.S. IPO's. Blockchain regulatory policy. H.R. 2144 - Token Taxonomy Act. Implementation of Foreign Investment Risk Review Modernization Act -- new export & investment restrictions. DEAL Act and Registered Investment Advisor rules. Volcker Rule reform. Private Securities Transparency and Reform Act, beneficial ownership reporting legislation. H.R. 5197 - Managed Stablecoins are Securities Act of 2019
Client expense: Not reported · Firm income: $60,000
2019 · fourth_quarter · Health Issues
Surprise Medical Bills S.2723, Mitigating Emergency Drug Shortages Act: reducing drug shortages H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management
2019 · fourth_quarter · Financial Institutions/Investments/Securities
Issues related to acceptance and use of digital assets and blockchain-based technologies S. 2563, ILLICIT CASH Act H.R. 1414, FinCEN Improvement Act of 2019 H.R. 2144, Token Taxonomy Act of 2019 H.R. 4234, To amend the Commodity Exchange Act with respect to the regulation of virtual currencies H.R. 5197, Managed Stablecoins are Securities Act of 2019 H.R. 4813, Keep Big Tech Out Of Finance Act
Client expense: $70,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2019 · fourth_quarter · Banking
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918
Client expense: $775,933 · Firm income: Not reported
2019 · fourth_quarter · Financial Institutions/Investments/Securities
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins are Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Banking
Digital Assets, crypto currencies, blockchain and related legislation; H.R. 2144, The Token Taxonomy Act of 2019. H.R. 4813 Keep Big Tech Out of Finance Act; H.R. 5197, Managed Stable Coins and Securities Act of 2019.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Surprise Medical Bills H.R. 3502, Protecting People From Surprise Medical Bills Act H.R. 2500, National Defense Authorization Act for Fiscal Year 2020: Krishnamoorthi amdt on drug shortages H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019: pre-authorization S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants Blood management
2019 · second_quarter · Health Issues
Surprise Medical Bills H.R. 3502, Protecting People From Surprise Medical Bills Act S. 1895, Lower Health Care Costs Act H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 1554, REDI Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and opioid abuse; Brain health Anesthesiologist Assistants
2019 · first_quarter · Health Issues
H.R. 3692, Addiction Treatment Access Improvement Act of 2017: Medically assisted treatment; opioids H.R. 5761, Ending Maternal Mortality Act of 2018: Maternal mortality H.R. 5718, Perioperative Reduction of Opioids Act: Opioids H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S. 2516, Alternatives to Opioids (ALTO) in the Emergency Department Act: Medically assisted treatment; opioids S.2680, Opioid Crisis Response Act of 2018: Medically assisted treatment; opioids S.2456, CARA 2.0 Act of 2018: Medically assisted treatment; opioids H.R. 1565, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs Comprehensive Addiction and Recovery Act of 2016 (PL 114-198) Affordable Care Act reform efforts H.R. 1628, American Health Care Act of 2017 S. Amdt. 1030 to H.R. 1628, "Graham-Cassidy" Better Care Reconciliation Act of 2017 H.R. 1492, Medical Controlled Substances Transportation Act of 2017 H.R. 1215, Protecting Access to Care Act of 2017 H.R. 3545, Overdose Prevention and Patient Safety Act H.R. 3446, Restoring Board Immunity Act of 2017: Professional Licensing S.2260, Opioids and STOP Pain Initiative ACT:opioids 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care H.R.3928, Truth in Healthcare Marketing Act of 2017 H.R. 5734, Resident Education Deferred Interest Act: student loan debt repayment for residents 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research - PCORI HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Anesthesia Research Funding (Pediatric and others) Scope of Practice FDA Operating Room Fires Naloxone FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Sequestration Opioids and Opioid abuse; Brain health
Client expense: $410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
Client expense: $380,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
Client expense: $340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Government targets: Commerce, Dept of (DOC), Director of National Intelligence (ODNI), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Client expense: $290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $310,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)